PDGFRB and melanoma: Rather, we observed upregulation of mural cell markers, including Pdgfrb and Cspg4, which have been identified as drivers of VM in breast cancer, glioblastoma, and melanoma through trans-differentiation of CSC-like cells to mural cells [78,79,80].